Malignant mesothelioma is among the rarest forms of cancer. It is also one of the most difficult to treat. Mesothelioma continues to be considered a fatal diagnosis, despite strides that have been made in improving longevity for many of those identified as having the disease. It is the challenge of treating the condition, as well…
The post Mesothelioma Patient Included in Broader Immunotherapy Study appeared first on Mesothelioma.net.
from Mesothelioma.net https://ift.tt/2HEcXgs
via IFTTT
Mesothelioma Patient Included in Broader Immunotherapy Study
![Mesothelioma Patient Included in Broader Immunotherapy Study]()
Reviewed by Unknown
on
March 18, 2019
Rating:
No comments: